Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Silva Amn"'
Autor:
Janine Soares, Cristiana Gaiteiro, Filipe Teixeira, Dylan Ferreira, Lara Santos L, Marta Relvas-Santos, José Oliveira M, Rita Ferreira, Silva Amn, Paula Paulo, Carlos M. Palmeira, Rui Freitas, José Alexandre Ferreira, Marta Cardoso, Andreia F. Peixoto
Bladder cancer constitutes one of the deadliest genitourinary diseases, especially when diagnosed at late stages. These tumours harbour microenvironmental niches characterized by low levels of oxygen (hypoxia) and limited glucose supply due to poor v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8707ae6af0da1809ee58c01de344c15
https://doi.org/10.1101/2021.02.14.431133
https://doi.org/10.1101/2021.02.14.431133
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Texto & Contexto Enfermagem; jan/mar2008, Vol. 17 Issue 1, p131-140, 10p
Autor:
Brito MB; Department of Gynecology and Obstetrics, Bahiana School of Medicine and Public Health (BSMPH), Salvador, Bahia, Brazil; Department of Gynecology and Obstetrics, Bahia Federal University (UFBA), Salvador, Bahia, Brazil. Electronic address: milenabrito@bahiana.edu.br., Boas AQV; Department of Gynecology and Obstetrics, Bahiana School of Medicine and Public Health (BSMPH), Salvador, Bahia, Brazil., Silva AMN; Department of Gynecology and Obstetrics, Bahiana School of Medicine and Public Health (BSMPH), Salvador, Bahia, Brazil., Miranda FP; Department of Gynecology and Obstetrics, Bahiana School of Medicine and Public Health (BSMPH), Salvador, Bahia, Brazil., Matos CBB; Department of Gynecology and Obstetrics, Bahiana School of Medicine and Public Health (BSMPH), Salvador, Bahia, Brazil., Santos OS; Department of Gynecology and Obstetrics, Bahiana School of Medicine and Public Health (BSMPH), Salvador, Bahia, Brazil., da Costa TP; Department of Gynecology and Obstetrics, Bahiana School of Medicine and Public Health (BSMPH), Salvador, Bahia, Brazil.
Publikováno v:
Journal of the National Medical Association [J Natl Med Assoc] 2024 Oct 19. Date of Electronic Publication: 2024 Oct 19.
Autor:
Oliveira JA; Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil., da Silva EG; Centro Universitário de Jaguariúna JaguariúnaSP Brazil Centro Universitário de Jaguariúna, Jaguariúna, SP, Brazil., Karasu AFG; Bezmialem Vakif University Istanbul Turkey Obstetrician and Gynecologist, Bezmialem Vakif University, Istanbul, Turkey., Silva AMN; Escola Bahiana de Medicina e Saúde Pública SalvadorBA Brazil Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil., Philip CE; Beaumont hospital Dublin Ireland Obstetrician and Gynecologist, Beaumont hospital, Dublin, Ireland.
Publikováno v:
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia [Rev Bras Ginecol Obstet] 2024 Sep 18; Vol. 46. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).
Autor:
Hider RC; Institute of Pharmaceutical Science, King's College London, London, SE1 9NH, UK. robert.hider@kcl.ac.uk., Silva AMN; LAQV-REQUIMTE, Departamento de Quimica E Bioquimica, Faculdade de Ciencias, Universidade Do Porto, Rua Do Campo Alegre, S/N, 4169-007, Porto, Portugal., Cilibrizzi A; Institute of Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Publikováno v:
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine [Biometals] 2024 May 21. Date of Electronic Publication: 2024 May 21.
Autor:
Freitas R; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Ferreira E; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Miranda A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Ferreira D; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Relvas-Santos M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal., Castro F; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Santos B; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal., Gonçalves M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal., Quintas S; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Peixoto A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Palmeira C; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; Immunology Department, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.; Health School of University Fernando Pessoa, 4249-004 Porto, Portugal., Silva AMN; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal., Santos LL; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Department of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal., Oliveira MJ; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Sarmento B; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; IUCS-CESPU, 4585-116 Gandra, Portugal., Ferreira JA; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.
Publikováno v:
ACS nano [ACS Nano] 2024 Apr 09; Vol. 18 (14), pp. 10088-10103. Date of Electronic Publication: 2024 Mar 27.
Autor:
Ferreira E; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Ferreira D; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS-Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S-Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB-Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Relvas-Santos M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS-Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S-Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB-Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal., Freitas R; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS-Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; i3S-Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB-Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Soares J; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS-Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal., Azevedo R; Institut Pasteur, Proteomics Core Facility, MSBio UtechS, 75015 Paris, France., Afonso LP; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Lima L; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Santos B; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Gonçalves M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Silva AMN; ICBAS-Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal., Santos LL; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Department of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal., Peixoto A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; i3S-Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; INEB-Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Ferreira JA; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; ICBAS-Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 19; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 19.
Autor:
Freitas R; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Miranda A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Ferreira D; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Relvas-Santos M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal., Castro F; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Ferreira E; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Gaiteiro C; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Soares J; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal., Cotton S; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal., Gonçalves M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal., Eiras M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal., Santos B; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal., Palmeira C; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; Immunology Department, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal; Health School of University Fernando Pessoa, 4249-004 Porto, Portugal., Correia MP; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP), 4200-072 Porto, Portugal., Oliveira MJ; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal., Sarmento B; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal; IUCS-CESPU, 4585-116 Gandra, Portugal., Peixoto A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal., Santos LL; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; Health School of University Fernando Pessoa, 4249-004 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal; Department of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal., Silva AMN; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal., Ferreira JA; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal. Electronic address: jose.a.ferreira@ipoporto.min-saude.pt.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Mar; Vol. 367, pp. 540-556. Date of Electronic Publication: 2024 Feb 03.
Autor:
Duarte TL; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. tduarte@ibmc.up.pt.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal. tduarte@ibmc.up.pt., Lopes M; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal., Oliveira M; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal., Santos AG; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal., Vasco C; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal., Reis JP; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal., Antunes AR; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal., Gonçalves A; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal., Chacim S; Serviço de Hematologia e Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. (IPO Porto), Porto, Portugal., Oliveira C; Laboratório de Citogenética, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal., Porto B; Laboratório de Citogenética, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal., Teles MJ; Departmento de Patologia Clínica, Centro Hospitalar Universitário São João, Porto, Portugal., Moreira AC; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal., Silva AMN; LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.; LAQV-REQUIMTE, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal., Schwessinger R; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Drakesmith H; MRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Henrique R; Serviço de Anatomia Patológica, IPO Porto, Porto, Portugal.; Departamento de Patologia e Imunologia Molecular, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal., Porto G; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; Departamento de Patologia e Imunologia Molecular, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal.; Serviço de Imuno-hemoterapia, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal., Duarte D; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. delfimd@med.up.pt.; Serviço de Hematologia e Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. (IPO Porto), Porto, Portugal. delfimd@med.up.pt.; Departmento de Biomedicina, Faculdade de Medicina da Universidade do Porto (FMUP), Porto, Portugal. delfimd@med.up.pt.; P.CCC - Porto Comprehensive Cancer Center Raquel Seruca, Porto, Portugal. delfimd@med.up.pt.
Publikováno v:
Leukemia [Leukemia] 2024 Jan; Vol. 38 (1), pp. 96-108. Date of Electronic Publication: 2023 Oct 19.